-transparent.png){kind=logo}
The effect of purified bacterial endotoxin was studied on human platelets in vitro. In adding up to 1 microgram/mL of a highly purified endotoxin, we found neither aggregation nor ATP release in heparinized or citrated human platelet-rich plasma. On the other hand; endotoxin at concentrations as low as a few ng/mL (as may be found in septic patients) caused platelet aggregation in both heparinized and citrated human whole blood, as monitored by change in impedance, free platelet count, and size. Unlike collagen, the platelet aggregation with endotoxin occurred after a long lag phase, developed slowly, and was rarely coupled with measurable release of ATP. The platelet aggregating effect of endotoxin was dose-dependent and modified by exposure of the endotoxin to ionizing radiation. Thus, the activation of human platelets by "solubilized" endotoxin in plasma requires the presence of other blood cells. We propose that the platelet effect is mediated by monocytes and/or neutrophils stimulated by endotoxin.
G Csako, and
E A Suba, and
R J Elin
November 1994,
Research in veterinary science,
G Csako, and
E A Suba, and
R J Elin
February 1999,
Thrombosis research,
G Csako, and
E A Suba, and
R J Elin
November 1998,
Artificial cells, blood substitutes, and immobilization biotechnology,
G Csako, and
E A Suba, and
R J Elin
April 1997,
Anesthesia and analgesia,
G Csako, and
E A Suba, and
R J Elin
October 2013,
Artificial organs,
G Csako, and
E A Suba, and
R J Elin
March 1996,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
G Csako, and
E A Suba, and
R J Elin
May 1994,
Thrombosis and haemostasis,
G Csako, and
E A Suba, and
R J Elin
December 1986,
Thrombosis research,
G Csako, and
E A Suba, and
R J Elin
December 1998,
Thrombosis research,
G Csako, and
E A Suba, and
R J Elin
January 1976,
Surgical forum,
